A new study shows the first evidence supporting a role for glucagon-like peptide-1 (GLP-1) receptor agonists in opioid reinforcement and analgesic responses. Using recently established models of opioid-taking and -seeking behaviors in rats, researchers have shown that systemic administration of the GLP-1 receptor agonist exendin-4 reduced oxycodone self-administration and the reinstatement of oxycodone-seeking behavior, an animal model of relapse.
from Latest Science News -- ScienceDaily https://ift.tt/2pnTTMU
via IFTTT
Friday, November 1, 2019
Novel research aims to identify new medications for the treatment of opioid use disorder
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment